×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
Biomarker
BEFREE
Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer : A systematic review and meta-analysis.
31512813 2020
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
AlteredExpression
BEFREE
The present results suggest that the postoperative CRP level can be a prognosticator in patients with esophageal cancer who have received perioperative steroid therapy and ERAS care.
30804146 2019
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
AlteredExpression
BEFREE
However, since elevated CRP levels are often observed in cStage III esophageal cancer , whether or not CRP still reflects the prognosis is unclear.
30167922 2019
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
Biomarker
BEFREE
We investigated the relationship between postoperative CRP values according to the postoperative period and prognosis in esophageal cancer .
30396980 2018
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
AlteredExpression
BEFREE
The present study aims to clarify the prognostic significance of postoperative CRP levels on the survival of patients with esophageal cancer .
28120093 2017
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
Biomarker
BEFREE
CRP value on POD 4 may be useful for predicting SICs in esophageal cancer patients who receive radical esophagectomy with perioperative steroid therapy and ERAS care.29202716 2017
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
AlteredExpression
BEFREE
A CRP genetic polymorphism associated with the tumoral expression of CRP in esophageal cancer .
22911253 2013
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
GeneticVariation
BEFREE
Promising markers that emerged for the prediction of overall survival in esophageal squamous cell cancer included VEGF (18 eligible studies, n=1476, HR=1.85, 95% CI, 1.55-2.21), cyclin D1 (12 eligible studies, n=1476, HR=1.82, 95% CI, 1.50-2.20), Ki-67 (3 eligible studies, n=308, HR=1.11, 95% CI, 0.70-1.78) and squamous cell carcinoma antigen (5 eligible studies, n=700, HR=1.28, 95% CI, 0.97-1.69); prognostic markers for esophageal adenocarcinoma included COX-2 (2 eligible studies, n=235, HR=3.06, 95% CI, 2.01-4.65) and HER-2 (3 eligible studies, n=291, HR=2.15, 95% CI, 1.39-3.33); prognostic markers for uncategorized EC s included p21 (9 eligible studies, n=858, HR=1.27, 95% CI, 0.75-2.16), p53 (31 eligible studies, n=2851, HR=1.34, 95% CI, 1.21-1.48), CRP (8 eligible studies, n=1382, HR=2.65, 95% CI, 1.64-4.27) and hemoglobin (5 eligible studies, n=544, HR=0.91, 95% CI, 0.83-1.00).
24206575 2013
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
GeneticVariation
BEFREE
In addition, we previously showed that the CRP 1846T/T genotype is related to lymph node metastasis in patients with esophageal cancer .
20686879 2010
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
AlteredExpression
BEFREE
The purpose of this study was to assess the association between CRP polymorphisms and acute-phase serum CRP levels after esophagectomy for thoracic esophageal cancer .
19801321 2009
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
Malignant neoplasm of esophagus
0.100
Biomarker
BEFREE
Two hundred and three newly diagnosed patients with gastric or oesophageal cancer had serum CRP and cytokine concentrations determined by ELISA.
17103073 2007